Topical estrogen to dominate global PVA drugs market through 2020, occupying 60% of the overall market
This market research study presents a detailed segmentation of the global postmenopausal vaginal atrophy (PVA) market by drug class (topical estrogen and systemic estrogen) and by geography (Americas, APAC, and EMEA). The key leading vendors in the market are Pfizer, Allergen, Shionogi, Novo Nordisk, and Teva Pharmaceutical. Technavio’s market research analysts estimate the global…